Convertible Promissory Notes and Notes Payable (Details Narrative) - USD ($) |
1 Months Ended | 12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|
Jul. 08, 2024 |
Feb. 22, 2023 |
Oct. 19, 2022 |
Jun. 30, 2022 |
Jun. 30, 2024 |
Jun. 30, 2023 |
Dec. 31, 2022 |
Jan. 18, 2024 |
Apr. 15, 2022 |
|
| Proceeds from related party | $ 100,000 | $ 0 | |||||||
| Common stock per share | $ 19.94 | ||||||||
| Interest rate | 8.50% | ||||||||
| Promissory note Feb 22, 2023 [Member] | |||||||||
| Promissory notes Principal amount | $ 560,000 | ||||||||
| Description of amendment to the promissory note | the Company executed an amendment to the promissory note with the investor, providing for the payment of interest only for 18 months at 12% per annum and thereafter the amortization of the note over a 12-month period, starting in June of 2025 | ||||||||
| Principal outstanding amount | $ 560,000 | ||||||||
| Common stock share purchase | 6,250 | ||||||||
| Common stock per share | $ 22.00 | ||||||||
| Promissory note Feb 22, 2023 One [Member] | |||||||||
| Promissory notes Principal amount | $ 2,150,000 | ||||||||
| Description of amendment to the promissory note | the Company executed an amendment to the promissory note with the investor, providing for the payment of interest only for 18 months at 12% per annum and thereafter the amortization of the note over a 12-month period, starting in June of 2025 | ||||||||
| Principal outstanding amount | $ 2,150,000 | ||||||||
| Common stock share purchase | 25,000 | ||||||||
| Common stock per share | $ 22.00 | ||||||||
| Note Agreement [Member] | |||||||||
| Holdback amount | $ 500,000 | ||||||||
| Convertible Notes, 36-Month Term Notes [Member] | |||||||||
| Proceeds from related party | 7,500,000 | ||||||||
| Fund received from accredited investors | 15,000,000 | ||||||||
| Sales of building | $ 4,300,000 | ||||||||
| Proceeds from notes | $ 2,780,200 | 6,678,506 | |||||||
| Description of agreement | The Company received a forbearance agreement from the bank until June 30, 2024 to return to compliance of the debt service ratio of 1.25 to 1, until that time the Company will pay an interest rate of 10% instead of the contractual terms of 4.8% | ||||||||
| Holdback amount | $ 3,000,000 | ||||||||
| Warrants acquire | $ 2,813 | ||||||||
| Exercise price | $ 88.80 | ||||||||
| Gain in the change of derivative liability | $ 3,540 | ||||||||
| Redeem warrants | $ 250,000 | ||||||||
| Allan Marshall [Member] | |||||||||
| Promissory notes Principal amount | $ 1,500,000 | ||||||||
| Description of amendment to the promissory note | the Company executed an amendment to the promissory note with Mr. Marshall, providing for the payment of interest only for 18 months at an interest rate of 12% per annum and thereafter the amortization of the note over a 12 month period, starting in June of 2025 | ||||||||
| Principal outstanding amount | $ 500,000 | ||||||||
| Common stock share purchase | 18,750 | ||||||||
| Common stock per share | $ 22.00 | ||||||||
| Interest rate | 8.50% | ||||||||
| Interest rate pik | 3.50% | ||||||||
| Cygnet Note [Member] | |||||||||
| Promissory notes Principal amount | $ 1,050,000 | ||||||||
| Common stock per share | $ 120.00 | ||||||||
| VitaMedica Note [Member] | |||||||||
| Promissory notes Principal amount | $ 500,000 | ||||||||
| Total convertible common stock | $ 100,000 | $ 1,000,000 | |||||||